zk200775
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 1996 (NCT00999284)
Timeline
1990s
- Jan 1, 1996
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Glutamate receptor AMPA 1/2INHIBITOR
Glutamate receptor AMPA 1/2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- (1,2,3,4-tetrahydro-7-morpholinyl-2,3-dioxo-6-(trifluoromethyl)quinoxalin-1-yl)methylphosphonate
- zk200775
- zk200775
- zk200775
- zk 200775
- zk-200775
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00999284 | Phase 1 | Dec 1, 1996 | Bayer, Humboldt University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bayer | For profit | 1 | 0 | 1 | 1996 |
| Humboldt University | Academic/Hospital | 1 | 1 | 1 | 1996 |
2 organizations
Page 1 / 1